TY - JOUR
T1 - Training future antimicrobial stewards in the ESCMID AMS certificate training programme
T2 - From knowledge to action
AU - Kuijpers, Suzanne M. E.
AU - Hulscher, Marlies E. J. L.
AU - Prins, Jan M.
AU - ten Oever, Jaap
AU - Schoffelen, Teske
AU - Milevska-Kostova, Neda
AU - Sigaloff, Kim C. E.
AU - Beovic, Bojana
AU - Schouten, Jeroen A.
N1 - Publisher Copyright:
© 2025 The Author(s). Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.
PY - 2025/10/1
Y1 - 2025/10/1
N2 - Objectives ESCMID has established the Antimicrobial Stewardship (AMS) Certificate programme to provide healthcare professionals with AMS expertise. This study evaluated the effectiveness of this 2-year training programme, measuring knowledge, skills and tangible results. Participants and methods This observational cohort study included participants in the first AMS certificate programme, which started in June 2022. The programme included online and live courses covering relevant AMS learning goals. Participants also carried out a local AMS project using a determinant analysis with pre- and post-intervention measurements. Data were collected through surveys, exams, and an evaluation of mandatory reports to assess progress across Kirkpatrick's four levels of learning: reaction, learning, behaviour and results. Results Forty participants from 22 countries took part in the programme. Individual courses were positively evaluated (reaction, level 1). All participants passed the final exam (learning, level 2). After 2 years, 35/40 (88%) submitted their AMS project reports (behaviour, level 3). In 31/35 (89%) of projects a post-intervention measurement was performed, of which 26/31 (84%) showed a positive effect on either process outcomes (e.g. increase in guideline adherence), quantity outcomes (e.g. reduced broad-spectrum antibiotic use), or patient outcomes (e.g. length of stay) (results, level 4). Conclusions The ESCMID AMS certificate programme effectively transfers knowledge and skills to participants who intend to develop ASPs in different clinical settings. Moreover, the course prompted the development and execution of local AMS projects with measurable impact on appropriate antibiotic use practices.
AB - Objectives ESCMID has established the Antimicrobial Stewardship (AMS) Certificate programme to provide healthcare professionals with AMS expertise. This study evaluated the effectiveness of this 2-year training programme, measuring knowledge, skills and tangible results. Participants and methods This observational cohort study included participants in the first AMS certificate programme, which started in June 2022. The programme included online and live courses covering relevant AMS learning goals. Participants also carried out a local AMS project using a determinant analysis with pre- and post-intervention measurements. Data were collected through surveys, exams, and an evaluation of mandatory reports to assess progress across Kirkpatrick's four levels of learning: reaction, learning, behaviour and results. Results Forty participants from 22 countries took part in the programme. Individual courses were positively evaluated (reaction, level 1). All participants passed the final exam (learning, level 2). After 2 years, 35/40 (88%) submitted their AMS project reports (behaviour, level 3). In 31/35 (89%) of projects a post-intervention measurement was performed, of which 26/31 (84%) showed a positive effect on either process outcomes (e.g. increase in guideline adherence), quantity outcomes (e.g. reduced broad-spectrum antibiotic use), or patient outcomes (e.g. length of stay) (results, level 4). Conclusions The ESCMID AMS certificate programme effectively transfers knowledge and skills to participants who intend to develop ASPs in different clinical settings. Moreover, the course prompted the development and execution of local AMS projects with measurable impact on appropriate antibiotic use practices.
UR - https://www.scopus.com/pages/publications/105016367634
U2 - 10.1093/jacamr/dlaf157
DO - 10.1093/jacamr/dlaf157
M3 - Article
C2 - 40995022
SN - 2632-1823
VL - 7
JO - JAC-Antimicrobial Resistance
JF - JAC-Antimicrobial Resistance
IS - 5
M1 - dlaf157
ER -